One-Stop Breast Tumour Diagnosis : KFSHRC Pioneers Same-Visit Biopsy
The King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully implemented an advanced interventional technique for diagnosing breast tumours that are undetectable by conventional imaging methods. This innovation enables physicians to obtain precise biopsy samples during the same visit, thereby accelerating the diagnostic process and initiating earlier treatment.
This shift in diagnostic approach addresses cases recorded in recent years where certain breast abnormalities could only be identified through contrast-enhanced imaging. Consequently, the hospital has adopted Contrast-Enhanced Mammography (CEM) as a precise clinical tool to overcome these diagnostic challenges.
Previously, the standard protocol necessitated scheduling a separate MRI-guided biopsy following initial imaging, often leading to redundant procedures, increased patient burden, higher healthcare costs, and delayed treatment initiation. In contrast, the new CEM-guided approach facilitates immediate and accurate tissue sampling during the same imaging session, eliminating the need for additional appointments.
KFSHRC brings substantial expertise to this advanced modality, having been the first to introduce contrast-enhanced mammography in the Kingdom nearly a decade ago. It remains one of the select healthcare centres in the Middle East that routinely employs this technique in clinical settings, reinforcing its diagnostic ecosystem and expediting treatment decisions with enhanced precision.
It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
09-07-2025
- Mid East Info
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition. When the early signs of illness appeared during the patient's first months of life, KFSHRC teams raced against time to stabilize her condition. She was diagnosed with a congenital deficiency in plasminogen, a protein essential for dissolving blood clots, resulting in fibrous deposits that posed serious threats to her tissues and organs. The complexity of her case posed both medical and quality-of-life challenges, requiring a comprehensive, multidisciplinary care system. This extended beyond medical treatment to include all facets of life-supporting care. Teams from nursing, nutrition, and information technology joined hematology and transplant specialists to ensure the young girl's well-being. In a reflection on the early days, the patient's father said: 'My daughter suffered from the moment she was born. She cried constantly and couldn't nurse. We lived in continuous worry with no clear answers until God opened a door of hope. Today, thanks to God first, and then to the remarkable healthcare capabilities provided by the Government of the Custodian of the Two Holy Mosques and His Royal Highness the Crown Prince, may God preserve them, we witness our daughter's recovery from this rare disease after two decades of struggle.' Throughout the years of treatment, the patient relied on regular intravenous doses of plasminogen, along with eye drops to reduce the disease's effect on her vision. The annual cost of treatment exceeded 6 million SAR, fully covered by the Saudi government. This reflects the Kingdom's profound commitment to human health and its investment in quality of life even in the most complex medical cases. Dr. Hazzaa Al-Zahrani, Director of Adult Hematology and Stem Cell Transplant Division at KFSHRC Riyadh and the supervising physician, explained that managing the case required a precise and long-term approach to prevent complications and ensure stability. The decision to proceed with a liver transplant came after careful consideration as an extraordinary therapeutic option for an exceptionally rare case. The success of the procedure marked a turning point in her medical journey and a beacon of hope for patients facing similar conditions worldwide. This approach is deeply rooted in the vision of King Faisal Specialist Hospital & Research Centre, which places the patient at the core of every practice and is committed to delivering integrated care where scientific expertise meets human compassion, in line with its mission to serve society at the highest standards.
Mid East Info
14-06-2025
- Mid East Info
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies - Middle East Business News and Information
King Faisal Specialist Hospital & Research Centre KFSHRC continues to redefine global healthcare through its Smart Hospital initiative, leveraging AI, simulation, and immersive technologies across its departments. These technologies have supported KFSHRC to enhance workforce training, clinical care, and operational efficiency. The Academic & Training Affairs (ATA) division is leading this transformation, deploying next-generation tools such as simulation labs, e-learning, and virtual reality (VR) to deliver hands-on, immersive training. These technologies allow healthcare professionals to rehearse complex procedures from emergency care to surgical planning, strengthening clinical preparedness and patient safety. The Patient Flow & Capacity Command Centre enhances operational efficiency by applying AI to forecast demand, manage resources, and monitor patient flow in real time. Since its launch, the Centre has completed over 170,000 interventions, cutting bed wait times from 32 to 6 hours and reducing emergency delays by 14%. In 2024 alone, the hospital received over 46,000 new patients and processed more than 79,000 referrals. Smart tools, such as the Noor robot, enhance the patient experience by providing real-time assistance and improving access to services. Across departments such as Radiology, Pathology, Genomics, and Oncology, AI enhances diagnosis, interpretation, early interventions and personalized care for complex diseases. Driving these innovations is KFSHRC's Centre for Healthcare Intelligence (CHI), which has developed over 20 AI applications in medical imaging, clinical decision support, and operations. In partnership with the Saudi Commission for Health Specialties, CHI also leads national AI training programs to build future-ready digital health talent. At the 2024 GAIN Summit CHI unveiled a generative AI platform to synthesize patient data, accelerate diagnostics, and streamline triage. KFSHRC ranks among Saudi Arabia's top 20 government entities in the 2025 Technology Adoption Readiness Index and received the 2024 Zimam Best AI Program Award, recognizing its leadership in AI, robotic surgery, and digital innovation. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings.
Mid East Info
13-06-2025
- Mid East Info
First of Its Kind in the Region
KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Patient In a medical achievement considered the first of its kind in the region, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has successfully performed an endoscopic sleeve gastroplasty (ESG) on a patient who had previously undergone a kidney transplant, a case that requires meticulous management of immunosuppressive medications and the prevention of any complications that could jeopardize the transplanted organ. This procedure marks a significant advancement in providing safe treatment solutions for transplant recipients, to improve their graft survival and quality of life. Known as Endoscopic Sleeve Gastroplasty (ESG), the procedure differs from surgical sleeve gastrectomy in that it requires no abdominal incisions, which is important for transplant patients. Instead, it uses an endoscope inserted through the mouth to suture the stomach internally, effectively reducing its volume and enabling the patient to lose weight and improve overall health. The procedure aimed to address obesity and metabolic, which are among the leading factors that can negatively impact the health of a transplanted kidney, increase cardiovascular risk, and reduce long-term patient outcomes. The procedure was performed by a multidisciplinary team of medical experts, led by Dr. Ehab Abufarhaneh, Consultant in Adult Transplant Gastroenterology and Hepatology. The team included gastroenterologists, an upper GI surgeon, transplant surgeons, transplant Nephrology, and transplant anaesthesiologists, all supported by highly trained nursing staff to ensure the highest level of safety, with particular focus on managing the patient's immunosuppressive regimen—critical to preserving kidney graft function. This achievement underscores the pivotal role of KFSHRC's Organ Transplant Centre of Excellence as a leading medical environment capable of delivering precise interventions for complex transplant cases. By adopting innovative techniques tailored to the unique needs of transplant patients and developing treatment protocols that address post-transplant challenges, the centre reinforces its position as a regional referral hub for cases beyond the scope of conventional treatment pathways. The success of this procedure further exemplifies KFSHRC's ongoing commitment to delivering advanced, patient-centred healthcare and fulfilling its vision of being the optimal choice for patients supported by an integrated ecosystem of education, research, and clinical excellence that aligns with the ambitions of Saudi Arabia's health sector. It is noteworthy that KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
